These alterations precede any observable weight gain but could contribute to the mechanisms of impaired insulin signaling (Matsuzawa-Nagata et al., 2008), which could ultimately lead to the development of type 2 diabetes (Wang et al., 2003), as well as other metabolic disorders (Lumeng and Saltiel, 2011). The gene discussed is INS; the disease is metabolic disease.